Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States Bernstein, E., VanBuren, J., Assassi, S., Castelino, F., Chung, L., Correia, C., Evnin, L., Frech, T., Startup, E., Gordon, J., Hant, F., Hummers, L., Sandorfi, N., Shah, A., Shanmugam, V., Steen, V., Khanna, D. WILEY. 2021: 795-798

View details for Web of Science ID 000744545201144